top of page

 PARTNERS 

EVI recognises the power of collaboration and engages with partners worldwide to harness the best knowledge and expertise from leaders in the field of vaccine research and development (R&D). 

OUR PARTNERS
Global network for worldwide impact

Moderna

USA

Moderna

​

Mologen AG

Germany

Mologen AG

​

NEC Corporation

Japan

NEC Corporation

​

NEC OncoImmunity AS

Norway

NEC OncoImmunity AS

​

NNE Pharmaplan GmbH

Germany

NNE Pharmaplan GmbH

​

National Institute of Allergy and Infectious Diseases (NIAID) - Laboratory of Malaria Immunology and Vaccinology

USA

National Institute of Allergy and Infectious Diseases (NIAID) - Laboratory of Malaria Immunology and Vaccinology

​

National Malaria Programmes of Benin

Benin

National Malaria Programmes of Benin

​

National Malaria Programmes of Guinea

Guinea

National Malaria Programmes of Guinea

​

National University of Ireland Galway

Ireland

National University of Ireland Galway

​

NeoVac Ltd.

United Kingdom

NeoVac Ltd.

​

Nigerian Institute of Medical Research (NIMR)

Nigeria

Nigerian Institute of Medical Research (NIMR)

​

Nobelpharma Co, Ltd.

Japan

Nobelpharma Co, Ltd.

​

Noguchi Memorial Institute for Medical Research

Ghana

Noguchi Memorial Institute for Medical Research

​

Nova ID FCT – Associação para a Inovação e Desenvolvimento de FCT

Portugal

Nova ID FCT – Associação para a Inovação e Desenvolvimento de FCT

​

Nova Laboratories

United Kingdom

Nova Laboratories

​

Novartis Vaccine Global Health

Italy

Novartis Vaccine Global Health

​

Novartis Vaccines and Diagnostics Srl

Italy

Novartis Vaccines and Diagnostics Srl

​

Novasep (formerly Henogen)

Belgium

Novasep (formerly Henogen)

​

Novavax AB

Sweden

Novavax AB

​

Novavax, United States of America (formerly ISCONOVA, Sweden)

USA

Novavax, United States of America (formerly ISCONOVA, Sweden)

​

Contact us

We'd love to hear from you!

For the latest updates follow EVI on:

  • LinkedIn
  • Twitter
  • YouTube
bottom of page